Tax Treatment
          
          
            You should review carefully the section entitled "Material U.S. Federal Income Tax Consequences" in the accompanying product
          
          
            supplement no. 4-I. In determining our reporting responsibilities we intend to treat (i) the notes for U.S. federal income tax purposes as
          
          
            prepaid forward contracts with associated contingent coupons and (ii) any Contingent Interest Payments as ordinary income, as
          
          
            described in the section entitled "Material U.S. Federal Income Tax Consequences - Tax Consequences to U.S. Holders - Notes
          
          
            Treated as Prepaid Forward Contracts with Associated Contingent Coupons" in the accompanying product supplement. Based on the
          
          
            advice of Davis Polk & Wardwell LLP, our special tax counsel, we believe that this is a reasonable treatment, but that there are other
          
          
            reasonable treatments that the IRS or a court may adopt, in which case the timing and character of any income or loss on the notes
          
          
            could be materially affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal
          
          
            income tax treatment of "prepaid forward contracts" and similar instruments. The notice focuses in particular on whether to require
          
          
            investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related
          
          
            topics, including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the
          
          
            underlying property to which the instruments are linked. While the notice requests comments on appropriate transition rules and
          
          
            effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the
          
          
            tax consequences of an investment in the notes, possibly with retroactive effect. The discussions above and in the accompanying
          
          
            product supplement do not address the consequences to taxpayers subject to special tax accounting rules under Section 451(b) of the
          
          
            Code. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes, including
          
          
            possible alternative treatments and the issues presented by the notice described above.
          
          
            Non-U.S. Holders - Tax Considerations. The U.S. federal income tax treatment of Contingent Interest Payments is uncertain, and
          
          
            although we believe it is reasonable to take a position that Contingent Interest Payments are not subject to U.S. withholding tax (at
          
          
            least if an applicable Form W-8 is provided), it is expected that withholding agents will (and we, if we are the withholding agent, intend
          
          
            to) withhold on any Contingent Interest Payment paid to a Non-U.S. Holder generally at a rate of 30% or at a reduced rate specified by
          
          
            an applicable income tax treaty under an "other income" or similar provision. We will not be required to pay any additional amounts with
          
          
            respect to amounts withheld. In order to claim an exemption from, or a reduction in, the 30% withholding tax, a Non-U.S. Holder of the
          
          
            notes must comply with certification requirements to establish that it is not a U.S. person and is eligible for such an exemption or
          
          
            reduction under an applicable tax treaty. If you are a Non-U.S. Holder, you should consult your tax adviser regarding the tax treatment
          
          
            of the notes, including the possibility of obtaining a refund of any withholding tax and the certification requirement described above.
          
          
            Section 871(m) of the Code and Treasury regulations promulgated thereunder ("Section 871(m)") generally impose a 30% withholding
          
          
            tax (unless an income tax treaty applies) on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain
          
          
            financial instruments linked to U.S. equities or indices that include U.S. equities. Section 871(m) provides certain exceptions to this
          
          
            withholding regime, including for instruments linked to certain broad-based indices that meet requirements set forth in the applicable
          
          
            Treasury regulations. Additionally, a recent IRS notice excludes from the scope of Section 871(m) instruments issued prior to January
          
          
            1, 2027 that do not have a delta of one with respect to underlying securities that could pay U.S.-source dividends for U.S. federal
          
          
            income tax purposes (each an "Underlying Security"). Based on certain determinations made by us, our special tax counsel is of the
          
          
            opinion that Section 871(m) should not apply to the notes with regard to Non-U.S. Holders. Our determination is not binding on the IRS,
          
          
            and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend on your particular
          
          
            circumstances, including whether you enter into other transactions with respect to an Underlying Security. You should consult your tax
          
          
            adviser regarding the potential application of Section 871(m) to the notes.
          
          
            In the event of any withholding on the notes, we will not be required to pay any additional amounts with respect to amounts so withheld.
          
          
            The Estimated Value of the Notes
          
          
            The estimated value of the notes set forth on the cover of this pricing supplement is equal to the sum of the values of the following
          
          
            hypothetical components: (1) a fixed-income debt component with the same maturity as the notes, valued using the internal funding
          
          
            rate described below, and (2) the derivative or derivatives underlying the economic terms of the notes. The estimated value of the notes
          
          
            does not represent a minimum price at which JPMS would be willing to buy your notes in any secondary market (if any exists) at any
          
          
            time. The internal funding rate used in the determination of the estimated value of the notes may differ from the market-implied funding
          
          
            rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be
          
          
            based on, among other things, our and our affiliates' view of the funding value of the notes as well as the higher issuance, operational
          
          
            and ongoing liability management costs of the notes in comparison to those costs for the conventional fixed income instruments of
          
          
            JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect,
          
          
            and is intended to approximate the prevailing market replacement funding rate for the notes. The use of an internal funding rate and
          
          
            any potential changes to that rate may have an adverse effect on the terms of the notes and any secondary market prices of the notes.
          
          
            For additional information, see "Selected Risk Considerations - The Estimated Value of the Notes Is Derived by Reference to an
          
          
            Internal Funding Rate" in this pricing supplement.